US Stock MarketDetailed Quotes

MLTX MoonLake Immunotherapeutics

Watchlist

55.470
+1.040+1.91%

Close Dec 2 16:00 ET

55.470
0.0000.00%

Post 16:01 ET

3.50BMarket Cap-43677P/E (TTM)

MoonLake Immunotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-173.22%-25.27M

-129.38%-27.89M

-65.64%-14.95M

23.47%-42.78M

-6.45%-12.34M

1.08%-9.25M

41.43%-12.16M

36.38%-9.02M

-55.89M

-11.6M

Net income from continuing operations

-210.81%-36.11M

-100.42%-24.76M

-14.38%-13.98M

31.67%-44.08M

52.10%-7.89M

21.18%-11.62M

29.07%-12.35M

23.05%-12.22M

---64.51M

---16.47M

Operating gains losses

91.09%-2.13K

97.99%-272

97.95%-272

-128.04%-85.25K

-145.21%-34.51K

-131.40%-23.96K

-118.18%-13.51K

-117.22%-13.27K

--304.03K

--76.34K

Depreciation and amortization

888.30%32.52K

754.73%28.11K

593.40%22.81K

6.47%13.16K

0.00%3.29K

-0.09%3.29K

0.03%3.29K

32.23%3.29K

--12.36K

--3.29K

Other non cash items

9,305.06%683.94K

5,310.86%333.47K

75.81%171.65K

119.47%484.76K

71.57%388.4K

71.87%-7.43K

-61.57%6.16K

1,902.28%97.63K

--220.88K

--226.38K

Change In working capital

752.81%8.28M

-309.62%-5.32M

-636.93%-2.84M

-293.55%-6.22M

-425.97%-6.42M

-64.71%971.22K

78.06%-1.3M

239.72%529.72K

---1.58M

--1.97M

-Change in receivables

-623.10%-730.25K

25.02%-180.94K

-172.15%-439.01K

-1,128.49%-839.73K

-187.66%-336.11K

-132.22%-100.99K

-1,083.98%-241.32K

62.73%-161.32K

---68.36K

--383.41K

-Change in prepaid assets

128.53%1.49M

-824.40%-8.18M

-175.44%-832.51K

-132.43%-6.35M

-2,507.34%-7.22M

2.62%650.1K

68.59%-884.52K

230.15%1.1M

---2.73M

--299.73K

-Change in payables and accrued expense

1,562.64%7.68M

2,607.56%3.35M

-210.83%-1.16M

-8.41%1.26M

-9.51%1.3M

-78.64%461.67K

95.73%-133.76K

-141.45%-373.74K

--1.37M

--1.44M

-Change in other current assets

--1

---1

---5.44K

---65.51K

--0

----

-Change in other current liabilities

-275.69%-148.63K

-705.97%-317.91K

-944.62%-405.58K

-45.82%-222.26K

---104.43K

---39.56K

---39.45K

---38.83K

---152.43K

----

Cash from discontinued investing activities

Operating cash flow

-173.22%-25.27M

-129.38%-27.89M

-65.64%-14.95M

23.47%-42.78M

-6.45%-12.34M

1.08%-9.25M

41.43%-12.16M

36.38%-9.02M

---55.89M

---11.6M

Investing cash flow

Cash flow from continuing investing activities

133.42%58.28M

-792.19%-87.74M

-246.60%-28.8M

22.13%-25.18M

1,080.30%116.87M

-312.96%-174.38M

633,802,550.00%12.68M

122,826.62%19.65M

-32.34M

9.9M

Net PPE purchase and sale

---132.19K

--0

---211.77K

-1,677.96%-284.63K

-28,463,300.00%-284.63K

--0

---16.01K

---1

Net investment purchase and sale

133.50%58.41M

-792.19%-87.74M

-245.52%-28.59M

22.97%-24.9M

1,083.17%117.15M

-312.96%-174.38M

--12.68M

--19.65M

---32.32M

--9.9M

Cash from discontinued investing activities

Investing cash flow

133.42%58.28M

-792.19%-87.74M

-246.60%-28.8M

22.13%-25.18M

1,080.30%116.87M

-312.96%-174.38M

633,802,550.00%12.68M

122,826.62%19.65M

---32.34M

--9.9M

Financing cash flow

Cash flow from continuing financing activities

183.1K

50.98M

300.78%479.7M

749,475.71%28.42M

331.09%451.29M

119.69M

3.79K

Net issuance payments of debt

----

--0

----

---15M

--0

Net common stock issuance

--0

--52.54M

--482.45M

--31.17M

--0

--451.29M

--0

Proceeds from stock option exercised by employees

----

--0

----

--3.79K

----

Net other financing activities

--91.8K

--0

---1.56M

-102.04%-2.75M

----

--134.69M

--0

Cash from discontinued financing activities

Financing cash flow

--183.1K

--0

--50.98M

300.78%479.7M

749,475.71%28.42M

--0

331.09%451.29M

--0

--119.69M

--3.79K

Net cash flow

Beginning cash position

-31.69%342.79M

814.52%458.44M

1,042.04%451.17M

391.43%39.51M

672.16%318.17M

441.26%501.79M

467.45%50.13M

391.43%39.51M

--8.04M

--41.2M

Current changes in cash

118.08%33.19M

-125.59%-115.63M

-31.99%7.23M

1,208.84%411.74M

7,962.69%132.94M

-256.02%-183.63M

438.34%451.8M

1,225.00%10.62M

--31.46M

---1.69M

Effect of exchange rate changes

-6,600.94%-325.44K

88.30%-16.9K

8,786.92%46.48K

-981.81%-75.31K

881.32%64.74K

-93.26%5.01K

-183.38%-144.52K

91.77%-535

--8.54K

---8.29K

End cash Position

18.07%375.66M

-31.69%342.79M

814.52%458.44M

1,042.04%451.17M

672.16%318.17M

441.26%501.79M

467.45%50.13M

--39.51M

Free cash flow

-174.65%-25.41M

-129.38%-27.89M

-67.99%-15.16M

22.98%-43.06M

-8.91%-12.63M

1.08%-9.25M

41.43%-12.16M

36.46%-9.02M

---55.91M

---11.6M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-173.22%-25.27M	-129.38%-27.89M	-65.64%-14.95M	23.47%-42.78M	-6.45%-12.34M	1.08%-9.25M	41.43%-12.16M	36.38%-9.02M	-55.89M	-11.6M
Net income from continuing operations	-210.81%-36.11M	-100.42%-24.76M	-14.38%-13.98M	31.67%-44.08M	52.10%-7.89M	21.18%-11.62M	29.07%-12.35M	23.05%-12.22M	---64.51M	---16.47M
Operating gains losses	91.09%-2.13K	97.99%-272	97.95%-272	-128.04%-85.25K	-145.21%-34.51K	-131.40%-23.96K	-118.18%-13.51K	-117.22%-13.27K	--304.03K	--76.34K
Depreciation and amortization	888.30%32.52K	754.73%28.11K	593.40%22.81K	6.47%13.16K	0.00%3.29K	-0.09%3.29K	0.03%3.29K	32.23%3.29K	--12.36K	--3.29K
Other non cash items	9,305.06%683.94K	5,310.86%333.47K	75.81%171.65K	119.47%484.76K	71.57%388.4K	71.87%-7.43K	-61.57%6.16K	1,902.28%97.63K	--220.88K	--226.38K
Change In working capital	752.81%8.28M	-309.62%-5.32M	-636.93%-2.84M	-293.55%-6.22M	-425.97%-6.42M	-64.71%971.22K	78.06%-1.3M	239.72%529.72K	---1.58M	--1.97M
-Change in receivables	-623.10%-730.25K	25.02%-180.94K	-172.15%-439.01K	-1,128.49%-839.73K	-187.66%-336.11K	-132.22%-100.99K	-1,083.98%-241.32K	62.73%-161.32K	---68.36K	--383.41K
-Change in prepaid assets	128.53%1.49M	-824.40%-8.18M	-175.44%-832.51K	-132.43%-6.35M	-2,507.34%-7.22M	2.62%650.1K	68.59%-884.52K	230.15%1.1M	---2.73M	--299.73K
-Change in payables and accrued expense	1,562.64%7.68M	2,607.56%3.35M	-210.83%-1.16M	-8.41%1.26M	-9.51%1.3M	-78.64%461.67K	95.73%-133.76K	-141.45%-373.74K	--1.37M	--1.44M
-Change in other current assets	--1	---1	---5.44K	---65.51K	---65.51K	--0	--0	--0	--0	----
-Change in other current liabilities	-275.69%-148.63K	-705.97%-317.91K	-944.62%-405.58K	-45.82%-222.26K	---104.43K	---39.56K	---39.45K	---38.83K	---152.43K	----
Cash from discontinued investing activities
Operating cash flow	-173.22%-25.27M	-129.38%-27.89M	-65.64%-14.95M	23.47%-42.78M	-6.45%-12.34M	1.08%-9.25M	41.43%-12.16M	36.38%-9.02M	---55.89M	---11.6M
Investing cash flow
Cash flow from continuing investing activities	133.42%58.28M	-792.19%-87.74M	-246.60%-28.8M	22.13%-25.18M	1,080.30%116.87M	-312.96%-174.38M	633,802,550.00%12.68M	122,826.62%19.65M	-32.34M	9.9M
Net PPE purchase and sale	---132.19K	--0	---211.77K	-1,677.96%-284.63K	-28,463,300.00%-284.63K	--0	--0	--0	---16.01K	---1
Net investment purchase and sale	133.50%58.41M	-792.19%-87.74M	-245.52%-28.59M	22.97%-24.9M	1,083.17%117.15M	-312.96%-174.38M	--12.68M	--19.65M	---32.32M	--9.9M
Cash from discontinued investing activities
Investing cash flow	133.42%58.28M	-792.19%-87.74M	-246.60%-28.8M	22.13%-25.18M	1,080.30%116.87M	-312.96%-174.38M	633,802,550.00%12.68M	122,826.62%19.65M	---32.34M	--9.9M
Financing cash flow
Cash flow from continuing financing activities	183.1K	0	50.98M	300.78%479.7M	749,475.71%28.42M	0	331.09%451.29M	0	119.69M	3.79K
Net issuance payments of debt	----	----	----	--0	----	----	----	----	---15M	--0
Net common stock issuance	--0	--0	--52.54M	--482.45M	--31.17M	--0	--451.29M	--0	--0	--0
Proceeds from stock option exercised by employees	----	----	----	--0	--0	----	----	----	--3.79K	----
Net other financing activities	--91.8K	--0	---1.56M	-102.04%-2.75M	----	----	----	----	--134.69M	--0
Cash from discontinued financing activities
Financing cash flow	--183.1K	--0	--50.98M	300.78%479.7M	749,475.71%28.42M	--0	331.09%451.29M	--0	--119.69M	--3.79K
Net cash flow
Beginning cash position	-31.69%342.79M	814.52%458.44M	1,042.04%451.17M	391.43%39.51M	672.16%318.17M	441.26%501.79M	467.45%50.13M	391.43%39.51M	--8.04M	--41.2M
Current changes in cash	118.08%33.19M	-125.59%-115.63M	-31.99%7.23M	1,208.84%411.74M	7,962.69%132.94M	-256.02%-183.63M	438.34%451.8M	1,225.00%10.62M	--31.46M	---1.69M
Effect of exchange rate changes	-6,600.94%-325.44K	88.30%-16.9K	8,786.92%46.48K	-981.81%-75.31K	881.32%64.74K	-93.26%5.01K	-183.38%-144.52K	91.77%-535	--8.54K	---8.29K
End cash Position	18.07%375.66M	-31.69%342.79M	814.52%458.44M	1,042.04%451.17M	1,042.04%451.17M	672.16%318.17M	441.26%501.79M	467.45%50.13M	--39.51M	--39.51M
Free cash flow	-174.65%-25.41M	-129.38%-27.89M	-67.99%-15.16M	22.98%-43.06M	-8.91%-12.63M	1.08%-9.25M	41.43%-12.16M	36.46%-9.02M	---55.91M	---11.6M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data